Emapunil

N/A

Report date: 2026/01/21 20:00:47
NME

Base Information

Drug NameEmapunil
Drug Alias Name依马普尼emapunilumemapuniloSX-5216AC-5216 +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranslocator protein stimulants
TargetsTranslocator protein
Therapy Area/IndicationsAnxiety DisordersAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSumitomo Dainippon
China Registration ClassN/A

Develop Information

Active CompaniesImperial College London
Inactive CompaniesNovartis Pharma Ag
Active IndicationsAlzheimer Disease
Inactive IndicationsAnxiety Disorders

Other Information

ATC CodeN/A
Related LinksWikipedia